The present disclosure relates to rotary pumps and, in particular, to axial flow blood pumps having a generally cylindrical rotor suspended within a corresponding cylindrical housing having a blood inlet at one end and blood outlet at another end, and motor components to provide rotational energy to spin the rotor and pump blood fluid longitudinally through the housing from the housing inlet to the housing outlet.
The known axial flow pumps for blood have the advantage of narrow radial width, when compared with centrifugal flow pumps. They may therefore be used for intra-vascular or intra-heart blood pumping assistance. Axial flow pumps typically have a cylindrical housing with an inlet at one end, an outlet at the opposite end, and a rotor within the housing which has thin impeller blades or vanes attached to and protruding radially outwardly from the rotor. Thus, as the rotor rotates, the blades add work to the fluid, propelling the fluid through the housing from the housing inlet to the housing outlet.
A suspension system is provided to maintain the rotor in a desired position within the housing, and an electromagnetic motor is provided to spin the rotor. The rotor may be mechanically, magnetically or hydrodynamically suspended within the blood flow passage. A combination of such suspension techniques may be utilized.
Typically in the prior art, the rotor is suspended by mechanical bearings or bushings, some with a rotor shaft protruding through the pump housing to a motor drive mechanism. Magnetic suspension is also known, as in U.S. Pat. Nos. 6,368,083 and 5,840,070. The blood discharged from the pump, flows parallel to the axis of rotation of the rotor.
Axial blood flow pumps have heretofore used a thin blade design, with the motor magnets being placed either in the rotor shaft, relatively far away from the surrounding stator, as in pumps by Jarvik and Incor, or they use small magnets placed within the thin blades, as in a pump made by MicroMed. Both of these approaches tend to reduce the motor torque capacity and efficiency, and they require mechanical rotor support involving abutting surfaces that move and wear against each other in rotation.
It is desirable for blood pumps, whether internally or externally located, to be more tolerant of flow variations than the previous thin blade designs and to exhibit low hemolysis, good resistance to thrombosis, adequate system efficiency, and very high reliability for the expected duration of use for the device. Internally located blood pumps are also subject to anatomical compatibility design constraints and the need for elimination of mechanical wear and associated failure modes in order to provide successful, long-term, implantable devices.
While the pump of this invention is described in terms of a blood pump, it is also contemplated that the pump might be used for pumping chemically difficult fluids or non-magnetic fluids, where a sealless design is highly desirable, and the fluid must be gently handled for various reasons, for example because it is unstable to mechanical stress, causing decomposition and even explosiveness, or because it is another complex, biological fluid besides blood, having critical stability parameters.
In accordance with the present invention an axial flow sealless and wearless blood pump is provided which comprises a tubular pump housing having a blood inlet at one open end and a blood outlet at the other open end opposite the inlet. A cylindrical rotor is suspended within the housing tube. The rotor comprises a plurality of peripheral and radial surfaces to engage and create pressure to assist in movement of the blood through the housing from the inlet end to the outlet end. A motor is provided to cause the rotor to spin within the housing. In one embodiment, the motor stator includes electrically conductive coils located external to or within the housing tube. A plurality of magnetic motor drive poles is provided on the rotor, spaced about its peripheral surfaces. The stator coil provides magnetic flux to cause the rotor to spin.
The rotor comprises a cylindrical body having a leading edge portion for engaging blood entering the housing at the inlet and a trailing edge portion for enhancing the discharge of the blood at the outlet of the housing. The rotor comprises one or more grooves each extending from an entry channel at the leading edge portion of the rotor to an exit channel at the trailing edge portion so as to define a plurality of arcuate peripheral land areas therebetween on the surface of the rotor. The sidewall surfaces defining each groove extend radially to the rotor surface but are not necessarily parallel to each other. In some embodiments each groove has a central portion defining a flow channel curved at least partially around the rotational axis of the rotor and in fluid flow communication with a substantially axially directed channel at the trailing edge portion of the rotor. The sidewalls of the grooves add axial thrust to the blood when the rotor is spinning and impart a rotational momentum to the flow of blood downstream of the rotor. In some embodiments, the central portion of each groove defines a narrower flow channel than is provided at its entry and exit channels. In some embodiments each groove is wider at its exit channel than at its entry channel to enhance the exit flow characteristics of the blood. In one embodiment, the combined total width of the central portions of the groove flow channels is substantially equal to or less than the collective, total arcuate widths of the peripheral land areas formed between the groove flow channels. The flow channels along the rotor may be helical along some portions of the rotor and generally axial directed along other portions of the rotor.
A plurality of hydrodynamic thrust bearing surfaces is provided on each of the peripheral surfaces of the land areas of the rotor. The bearing surfaces create fluid pressure at the periphery of the rotor thereby imparting radially symmetrical forces to the rotor, which maintain the radial position of the rotor within the housing when the rotor is spinning, and to provide good washing near the surrounding housing for increased resistance to thrombosis.
The land surface areas of the rotor between the flow channels of the grooves are each wider and longer at their peripheries than the thin blades of prior art axial flow blood pumps. This permits the emplacement or formation of relatively large motor drive magnets at or near the periphery of the rotor. Large drive magnets in the rotor increase magnetic force, and their placement at the rotor periphery reduces the gap between the magnetic poles of the rotor and magnetic flux generating coils of a motor stator. This arrangement improves motor torque capacity and electromagnetic efficiency of the pump. Axial magnetic stiffness provided by a motor of radial flux gap design may be used to assist in holding the rotor in its axial position within the housing.
A magnetic bearing system may be provided, as well as hydrodynamic thrust bearings, to help maintain the position of the rotor radially or axially within the tubular housing. Magnetic poles to assist in suspension of the rotor within the housing may be placed within the peripheral land surfaces between the grooves of the rotor to be attracted to or repelled by corresponding magnetic poles within or adjacent the surrounding pump housing.
In one embodiment, magnetic bearings may be used instead of hydrodynamic thrust bearings, to provide an all magnetic suspension system. Such magnetic bearings could be positioned or formed in the peripheral land areas of the rotor either forward or aft of the location of the motor drive magnets. Accordingly, a rotor in accordance with this invention does not require mechanical supporting structures upstream or downstream thereof. Hydrodynamic thrust bearings, with or without magnetic bearings, or exclusive magnetic bearings, will be sufficient to maintain the rotor in desired position during operation.
In some embodiments, the configuration of the tubular pump housing may include an annular sloped interior surface near the rotor's leading or trailing edge portions to provide a mechanical stop for axial movement of the rotor. Such a configuration provides additional axial support for the rotor, as may become necessary in the event of shock loading to ensure that the rotor remains in proper position within the housing. Alternately, a split housing configuration might be provided, with annular sloped surfaces at both the rotor leading and trailing edge portions, to provide radial support and axial support in both axial directions. The blood pump may also utilize one or more upstream and downstream flow straighteners or diffusers to enhance flow characteristics of blood as it enters or exits the pump.
A controller is provided to run the motor at a set rotational speed, which may be set, for example by the attending physician. Alternatively, the motor may be run at a rotational speed which varies in response to a physiological control algorithm.
Unlike axial flow pump designs heretofore using radial thin blade impellers, upstream and downstream struts or stator elements which may serve as flow straighteners or diffusers may be useful but are not required. The absence of these upstream and downstream flow straighteners permits a simpler mechanical design, with fewer axial tolerance concerns associated with their placement. Moreover, the absence of upstream flow straighteners or diffusers permits a pre-swirl to the upstream blood flow pattern that may serve to improve resistance to thrombosis.
In some embodiments, a volute may be used at the output end of the housing to improve the output flow characteristics of the blood. For example, a volute may be used to redirect the blood flow in a direction normal to the rotational axis of the pump. A volute may improve the output blood flow characteristics of an axial flow pump by converting rotational kinetic energy in the output flow from the axial flow pump to a slower output velocity having sufficient pressure for discharge into the vascular system.
The blood pump of this invention might be implanted within the vascular system or located within the chest cavity of a patient, such as the pericardial space, abdomen, or subcutaneously near the skin, in a manner similar to pacemaker implantation. Likewise, the pump may be kept external to the body for shorter term vascular circulatory support. Also multi-rotor or ganged rotor pumps having a plurality of axially aligned axial flow pumps of the type described herein could be used to provide single or bi-ventricular support, or even total circulation for the patient in the manner of a full, artificial heart. Moreover, such multi-stage pumps can be constructed with smaller diameter tubular housing for intra-vascular implantation.
A more complete appreciation of the present invention and many of the attendant advantages thereof will be better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:
In describing the preferred embodiments of the present disclosure illustrated in the drawings, specific terminology is employed for sake of clarity. However, the present disclosure is not intended to be limited to the specific terminology so selected, and it is to be understood that each specific element includes all technical equivalents which operate in a similar manner.
Referring now to the drawings and in particular to
A substantially cylindrical rotor 14 is positioned within the lumen of the pump housing 12, and acts as an impeller for pumping fluid within the housing. In one embodiment, the rotor 14 is provided with a tapered leading edge 14A which is contoured to follow the diverging portion 13A of the interior diameter of the housing. The converging and diverging diameter portions 13 and 13A may act as a mechanical stop to maintain the rotor 14 in proper axial position within the tubular housing if, for example, an external shock would tend to jolt the rotor out of its working axial position. In some embodiments the tapered leading edge 14A of the rotor may be provided with a hydrodynamic thrust bearing surface of the type described below to cooperate with the surface of the diverging diameter portion 13A of the housing 12 for additional protection against axial shock loading. The alignment between the housing diverging diameter portion 13A and the tapered leading edge 14A of the rotor could also be utilized to provide a magnetic axial preload at the rotor's leading edge, similar to that described below with respect to its trailing edge, to assist the rotor in maintaining its suspended and wearless position within the housing.
Rotor 14 comprises one or more grooves 22 each of which extends from an entry section or inlet channel 22A at the leading edge 14A to an exit section or outlet channel 22B at the trailing edge 14B of the rotor. The grooves 22 define fluid flow channels across the rotor. In some embodiments a plurality of grooves 22 formed in the rotor 14 are spaced apart and define a plurality of peripheral land areas 35 therebetween. Each groove is defined by a pair of side walls 16 extending substantially radially to the rotational axis of the rotor, but not necessarily parallel to each other.
As shown in
In one embodiment, the number of grooves 22 may be in the range of from 2 to 8, with four being typical. Irrespective of the number of grooves, their collective widths at the outer periphery 23 of the rotor 14 (
In this embodiment, the depth of each of the grooves 22 is greater than the radial extent of the blades in comparable and conventional thin blade axial pump designs. For example, for heart pump uses, the average depth of the grooves 22 from their outer perimeters may fall within the range of from 1 mm to 5 mm. In some embodiments the average depth of the grooves is approximately ⅓ the diameter of the rotor, but is less than the radius of the rotor. In other embodiments the grooves may be deeper at the entry channel 22A at the leading edge of the rotor and shallower at the exit channel 22B at the trailing edge of the rotor.
With reference to
With reference to
The motor may be a three phase, brushless DC motor. In one embodiment the motor could be a toroidal, three phase and wye connected design. The stator may have a back iron design which is consistent with a typical radial flux gap motor. If desired, the motor stator can comprise a separate, hermetically sealed enclosure 40 that slides over the tubular housing 12 into position. A braised weld ring to the enclosure 40 outer surface may be used to secure the motor stator housing in position. Laser welding is one possibility for securing the motor stator enclosure 40 to the housing and obtaining a hermetic seal. The specific technology for accomplishing this known in the prior art.
Referring to
Referring to
As the rotor rotates, the respective thrust bearings, 44, 46 on each land area 35 scoop blood onto the bearing surfaces whereby it flows between the bearing surfaces and the inner wall of the tubular pump housing. The effect of the tapered configuration of the thrust bearing surfaces is to force blood to flow through a decreasing or constricting area created between the bearing surfaces and the inner wall of the tubular pump housing. This results in increasing fluid pressure upstream within the constriction, which pressure acts against the bearing surface areas and produces a net symmetrical force for radial support of the spinning rotor. That hydrodynamic thrust bearings act in this way to cause radial pressure on a rotor is well known to the art generally, as in U.S. Pat. No. 5,840,070. The hydrodynamic force that is thus created on the surfaces of the rotor land areas tends to hold the rotor suspended and centered within the lumen of the tubular housing 12 in a manner shown in
In some embodiments, hydrodynamic thrust bearing surfaces are created on the leading or trailing edge portions of the rotor. For example, with reference to
Hydrodynamic thrust bearing surfaces may also be located on the rotor near its trailing edge 14B, in which event the inner diameter of the tubular pump housing near its outlet end 11A would be constricted as shown in dotted lines in
Hydrodynamic thrust bearings on the outer periphery of the rotor provide good surface washing. Centrifugal forces created by thrust bearings tend to push fluid toward the periphery of the housing interior, providing increased blood flow, which can improve the pump's resistance to thrombosis. In contrast, hydrodynamic bearings in the prior art which are closer to the axis of rotation have reduced surface washing, resulting in a greater possibility of blood coagulation. Thus, since by this invention, conditions are provided that reduce blood coagulation, a lower amount of anticoagulant may be used with the blood pump and patient, which may result in fewer patient adverse side effects. If desired, hydrodynamic thrust bearing surfaces may be aligned in a helical fashion on the surfaces of the rotor to improve surface washing by the moving blood as the rotor spins.
As an alternative to hydrodynamic thrust bearings acting axially on the rotor, permanent rotor retaining magnets maybe placed in each land area 35 within the lead, trailing or both ends of the rotor. One or more corresponding permanent magnets may be placed within or on the tubular pump housing adjacent each rotor retaining magnet to effect repulsive magnetic forces acting to retain the axial alignment of the rotor within the housing. By way of example only, a permanent magnet 56 is shown in
With reference to
An optional pressure relief surface downstream of each rotor thrust bearing surface may be provided to reduce hemolysis. This pressure relief surface consists of a portion of the peripheral land area that is contiguous with the rear end 48 of a thrust bearing surface and slightly diverges away from the housing wall. Blood passing over the thrust bearing surface is thereby directed across the pressure relief surface into an adjacent one of the grooves 22 formed in the rotor. Rounded surfaces 54 at the leading end of the rotor, seen in
In some embodiments, the rotor 14 may be produced by either machining, molding, or casting a single piece of ferromagnetic material, such as compression bonded neodymium or Alnico (aluminum-nickel alloy), or an alloy of about 70-80 percent by weight of platinum and about 20-30 percent by weight of cobalt. In some embodiments, from essentially 76-79 percent by weight of platinum is present in the alloy. In some embodiments, the alloy may contain essentially from 21-24 percent by weight of cobalt. In one embodiment, an integral, one-piece rotor consists of essentially 77.6 percent by weight of platinum and 22.4 percent by weight of cobalt. Such a rotor is conventionally heat treated to achieve good magnetic properties, and may be magnetized, with North and South magnetic poles, as desired.
An advantage of such a rotor is that a single, integral piece made from the platinum and cobalt alloy can be easily fabricated into complex shapes, using conventional metal working and casting methods. Also, such an alloy is magnetically isotropic, so that parts can be easily magnetized with a plurality of magnetic poles in any geometric orientation. These characteristics allow the rotor to be fabricated from a solid piece of the alloy, thus eliminating the need to build assemblies of magnets and support structures, as in the case of prior art ventricular assistance devices, with a resulting reduction of manufacturing costs. Additionally, the alloy used in this invention is biocompatible, and has high resistance to corrosion, also having a Rockwell hardness on the order of 31 Rc, which eliminates the need for a hard, outer coating. It will be understood that the rotor material may be isotropic or anisotropic, as desired.
After fabrication, the rotor may be treated with a conformal, protective polymer coating of an organic polymer such as Parylene, or silicone, to prevent against oxidation by forming a hermetic seal around the rotor. On top of this, a hard, lubricious protective coating may be applied over the conformal polymer coating, to protect against wear and abrasion. Such coatings may include chromium nitride, titanium-nitride, or other commercially available coatings such as ME92, Med Co 2000, or DLC. Alternatively, as stated above, the use of a biocompatible magnetically isotropic alloy such as a platinum-cobalt alloy obviates the use of the protective coating. Designed for a permanent heart ventricular assist device, such a rotor could be a cylindrical device having a 10 millimeters outer diameter and 20 millimeters length, providing flow rates of2-10 liters per minute against physiologic, differential blood pressures. Magnetization of the rotor land sections may occur before or after a coating application.
With reference to
Referring to
Referring to
Motor stators 36c, comprising electrically conductive coils are provided, one for each rotor, so that each of the respective rotors performs in a manner similar to that of the rotors described for previous embodiments, but for their connection with the common shaft. The rotors 14c and stators 36c may be of the same design as any of the previous embodiments, however, each rotor need not have the same number of grooves or land sections between the grooves.
Stator blades 66 of traditional thin blade design may be mounted to extend radially inwardly from the inner wall of pump housing 62 downstream of at least two of the three ganged rotors, although such blades are not normally required in the axial flow pumps of the present invention. The stator blades 66 serve to diminish the rotational momentum of the axial flow output from the rotors before the flow encounters the next rotor. This arrangement permits more hydraulic work to be added to the blood or other fluid. Any desired number of these generally radially extending blades 66 may be provided, if desired. Moreover, if desired, the leading or trailing end of each of the stator blades 66 may be provided with suitable hydrodynamic thrust bearing surfaces to provide additional axial support to the rotor. The stator blades 66 may also include integral permanent magnets to define magnetic bearings to support the rotor. Permanent magnets mounted in or on the appropriate leading or trailing ends of each rotor can provide repulsive magnet poles to assist in the axial stability of the rotors.
In the embodiment shown in
Referring to
In one embodiment, the independently rotatable rotors 14c rotate at the same rate. It will be understood that the rates of rotation of the multiple rotors may vary, one from the other, as desired. In some embodiments, one rotor may rotate clockwise, and be oriented such that its grooves tend to drive blood or other fluid through tubular housing 62 in the direction of arrow 63. An adjacent rotor may be oriented such that its grooves tend to drive blood in the same direction 63 upon counterclockwise rotation. Thus, the multiple rotors work together to drive fluid in direction 63, even while they rotate in opposite directions. An advantage of this arrangement is that a rotor rotating counterclockwise downstream from a clockwise rotating rotor tends to counteract the rotational momentum imparted to the pumped fluid by the upstream rotor. This permits more hydraulic work to be added to the fluid. Depending upon the power applied to the individual stators 36c, the respective rotors maybe driven at rotation rates which are similar, or different from each other, as may be desired. Adverse affects from misaligned motor drive waveforms are thereby reduced.
In some embodiments, the multi-rotor pump is free of stationary, swirl suppressing blades positioned within the housing and between the rotors. A need for such blades is diminished by counterrotating characteristics of the respective rotors.
In some embodiments, more than two rotors are present. Adjacent rotors will rotate in opposite directions from each other, so that clockwise rotating rotors are interspersed with counterclockwise rotating rotors in axially alignment within the pump housing.
A permanent ventricular assist device of multistage configuration as described above could have an outer diameter of six millimeters and a length of 15 millimeters, to provide flow rates of 2-8 liters per minute against physiological differential pressures, as previously described. Such a multi-stage pump could be used as a peripheral vessel blood insertion pump, operating outside of the body, or provide bi-ventricular support and even total artificial heart action. It will be understood, that the multiple rotors need not be ganged on a common shaft and that the motor stator for each rotor could be energized to effect clockwise or counterclockwise rotation of each rotor independently of the rotational spin of other adjacent rotors.
The motor stator 110 has three electrical cables 103 (seen best in the enlarged view of the motor stator in
Referring to
The motor stator ring 110 may be located on the outside the housing 104 and within the cannula 102a in the annular space formed between the housing 104 and the cannula 102a. The three phase control wires for the coils of the stator ring 110, described in detail above, are connected through the power and control cable conduit 120k that exits the pump through a port 118 which may be defined as part of the volute 106. A rotor 108, of the type described in detail above, may be magnetically or hydrodynamically suspended in operation within the housing 104 and centered within the stator ring 110 to provide an axial flow of the blood or fluid entering the inlet 116.
The volute 106 is sealed to the cannula 102a and the tubular housing 104 in a fluid-tight connection such that blood pumped by the rotor 108 is moved into a central chamber 114 (
As depicted in
Blood driven by the rotor 108 and entering the volute chamber from the pump chamber of the axial flow pump has a rotational or spiraling momentum around the rotational axis of the rotor. The rotational momentum of the flow creates lower pressure areas in a central portion of the blood flow just downstream of the rotor. To some extent the lower pressure area is alleviated by a tapered axial extension 24 (
Referring now to
Referring to
Referring to
In accordance with the present invention, blood outflow characteristics may be altered without the need for projecting blades or posts downstream of the axial flow pump. Shaped passageways designed to improve flow characteristics may be employed instead. With reference to
With reference to
Referring to
Referring to
Referring to
The inflows 183 and 184 may be made of a penetrable material such as a soft Dacron texture material so that it may be easily sutured to the patient's circulatory system. The inflows 183 and 184 may have a shape that is wider at the end that is connected to the patient's circulatory system than at the end that is connected to the pump 10. The inflows 183 and 184 may be elbowed so that the inflows 183 and 184 may be proximal to the outflows 185 and 186.
The first pump section 181 and the second pump section 182 may be attached together by a connecting member 180 such as a bracket or the like.
In this embodiment, the artificial heart does not require artificial vales thereby improving device reliability.
A balance member or atrial shunt or shunt may optionally be connected between the first and second inflows 183 and 184 to substantially equalize or balance the flow of blood through the first and second inflows 183 and 184. Thus, when the pressure in the first and second inflow members is unbalanced, blood may be shunted between the inflow members. The shunt may include two ends where one of the ends is connected to the first inflow 183 and the opposing end of the shunt is connected to the second inflow 184. The shunt 124 may be integrally formed with each of the inflows 183 and 184. The shunt may automatically equalize or balance the hydraulic blood flow through each of the first and second sections 181 and 182. The shunt may therefore prevent one side of the artificial heart from over pumping the other side of the heart
The first section 181 may be designed to pump more blood than the section 184. According to one embodiment, the first section 183 is designed to pump 15% more blood than the second section 182.
Power and control cables 120K may be used to power and control each pump 10.
The above specific embodiments are illustrative, and many variations can be introduced on these embodiments without departing from the spirit of the disclosure or from the scope of the appended claims. For example, elements and/or features of different illustrative embodiments may be combined with each other and/or substituted for each other within the scope of this disclosure and appended claims.
Number | Date | Country | Kind |
---|---|---|---|
PCT/US2005/035964 | Oct 2005 | WO | international |
PCT/US2005/042495 | Nov 2005 | WO | international |
This application is a continuation of U.S. patent application Ser. No. 15/151,058, filed May 10, 2016, which application is a continuation of U.S. patent application Ser. 14/327,971, filed Jul. 10, 2014, now U.S. Pat. No. 9,339,598, which is a continuation of U.S. patent application Ser. No. 11/992,997, filed Sep. 29, 2009, now U.S. Pat. No. 8,790,236. U.S. patent application Ser. No. 11/992,997 is a national phase entry under 35 U.S.C. § 371 of International Application No. PCT/US2006/021544, filed Jun. 2, 2006, published in English, which claims priority from International Application No. PCT/US2005/035964, filed Oct. 6, 2005, and to International Application No. PCT/US2005/042495, filed Nov. 22, 2005 and U.S. application Ser. No. 11/243,722, filed Oct. 5, 2005. The disclosures of all of the applications are hereby incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
50714 | Fritz | Oct 1865 | A |
2941477 | Dalton | Jun 1960 | A |
3426721 | Justinien | Feb 1969 | A |
3608088 | Dorman et al. | Sep 1971 | A |
3685059 | Bokros et al. | Aug 1972 | A |
4437815 | McMullen | Mar 1984 | A |
4589822 | Clausen et al. | May 1986 | A |
4595390 | Hakim et al. | Jun 1986 | A |
4615691 | Hakim et al. | Oct 1986 | A |
4625712 | Wampler | Dec 1986 | A |
4642036 | Young | Feb 1987 | A |
4688998 | Olsen et al. | Aug 1987 | A |
4753221 | Kensey et al. | Jun 1988 | A |
4779614 | Moise | Oct 1988 | A |
4817586 | Wampler | Apr 1989 | A |
4846152 | Wampler et al. | Jul 1989 | A |
4863461 | Jarvik | Sep 1989 | A |
4906229 | Wampler | Mar 1990 | A |
4908012 | Moise et al. | Mar 1990 | A |
4919647 | Nash | Apr 1990 | A |
4927407 | Dorman | May 1990 | A |
4944722 | Carriker et al. | Jul 1990 | A |
4957504 | Chardack | Sep 1990 | A |
4994078 | Jarvik | Feb 1991 | A |
4995857 | Arnold | Feb 1991 | A |
5061256 | Wampler | Oct 1991 | A |
5092879 | Jarvik | Mar 1992 | A |
5112200 | Isaacson et al. | May 1992 | A |
5209650 | Lemieux | May 1993 | A |
5211546 | Isaacson et al. | May 1993 | A |
5290227 | Pasque | Mar 1994 | A |
5290236 | Mathewson | Mar 1994 | A |
5344443 | Palma et al. | Sep 1994 | A |
5376114 | Jarvik | Dec 1994 | A |
5385581 | Bramm et al. | Jan 1995 | A |
5501574 | Raible | Mar 1996 | A |
5527159 | Bozeman, Jr. et al. | Jun 1996 | A |
5588812 | Taylor et al. | Dec 1996 | A |
5613935 | Jarvik | Mar 1997 | A |
5678306 | Bozeman, Jr. et al. | Oct 1997 | A |
5692882 | Bozeman, Jr. et al. | Dec 1997 | A |
5707218 | Maher et al. | Jan 1998 | A |
5713727 | Veronesi et al. | Feb 1998 | A |
5746709 | Rom et al. | May 1998 | A |
5776190 | Jarvik | Jul 1998 | A |
5824070 | Jarvik | Oct 1998 | A |
5840070 | Wampler | Nov 1998 | A |
5851174 | Jarvik et al. | Dec 1998 | A |
5868763 | Spence et al. | Feb 1999 | A |
5888241 | Jarvik | Mar 1999 | A |
5911685 | Siess et al. | Jun 1999 | A |
5924848 | Izraelev | Jul 1999 | A |
5941813 | Sievers et al. | Aug 1999 | A |
5947892 | Benkowski et al. | Sep 1999 | A |
5965089 | Jarvik et al. | Oct 1999 | A |
6015272 | Antaki et al. | Jan 2000 | A |
6019722 | Spence et al. | Feb 2000 | A |
6053705 | Schob et al. | Apr 2000 | A |
6058593 | Siess | May 2000 | A |
6068588 | Goldowsky | May 2000 | A |
6100618 | Schoeb et al. | Aug 2000 | A |
6116862 | Rau et al. | Sep 2000 | A |
6120537 | Wampler | Sep 2000 | A |
6135729 | Aber | Oct 2000 | A |
6155969 | Schima et al. | Dec 2000 | A |
6162233 | Williamson, IV et al. | Dec 2000 | A |
6176822 | Nix et al. | Jan 2001 | B1 |
6190397 | Spence et al. | Feb 2001 | B1 |
6200260 | Bolling | Mar 2001 | B1 |
6227797 | Watterson et al. | May 2001 | B1 |
6227820 | Jarvik | May 2001 | B1 |
6234635 | Seitzinger et al. | May 2001 | B1 |
6234772 | Wampler et al. | May 2001 | B1 |
6234998 | Wampler | May 2001 | B1 |
6244835 | Antaki et al. | Jun 2001 | B1 |
6247892 | Kazatchkov et al. | Jun 2001 | B1 |
6250880 | Woodard et al. | Jun 2001 | B1 |
6254359 | Aber | Jul 2001 | B1 |
6254617 | Spence et al. | Jul 2001 | B1 |
6299575 | Bolling | Oct 2001 | B1 |
6306116 | Hancock | Oct 2001 | B1 |
6368083 | Wampler | Apr 2002 | B1 |
6387037 | Bolling et al. | May 2002 | B1 |
6390969 | Bolling et al. | May 2002 | B1 |
6419696 | Ortiz et al. | Jul 2002 | B1 |
6428464 | Bolling | Aug 2002 | B1 |
6439845 | Veres | Aug 2002 | B1 |
6447265 | Antaki et al. | Sep 2002 | B1 |
6447266 | Antaki et al. | Sep 2002 | B2 |
6488692 | Spence et al. | Dec 2002 | B1 |
6527521 | Noda | Mar 2003 | B2 |
6527699 | Goldowsky | Mar 2003 | B1 |
6530876 | Spence | Mar 2003 | B1 |
6581476 | Fremerey | Jun 2003 | B1 |
6595743 | Kazatchkov et al. | Jul 2003 | B1 |
6610004 | Viole et al. | Aug 2003 | B2 |
6610008 | Spence et al. | Aug 2003 | B1 |
6619291 | Hlavka et al. | Sep 2003 | B2 |
6641378 | Davis et al. | Nov 2003 | B2 |
6652543 | Spence et al. | Nov 2003 | B2 |
6659270 | Williamson, IV et al. | Dec 2003 | B2 |
6685621 | Bolling et al. | Feb 2004 | B2 |
6688661 | Yamamoto | Feb 2004 | B2 |
6688861 | Wampler | Feb 2004 | B2 |
6716157 | Goldowsky | Apr 2004 | B2 |
6716189 | Jarvik et al. | Apr 2004 | B1 |
6717311 | Locke | Apr 2004 | B2 |
6719791 | Nusser et al. | Apr 2004 | B1 |
6730121 | Ortiz et al. | May 2004 | B2 |
6742999 | Nusser et al. | Jun 2004 | B1 |
6752602 | Schulte Eistrup et al. | Jun 2004 | B2 |
6794789 | Siess et al. | Sep 2004 | B2 |
6869567 | Kretchmer | Mar 2005 | B2 |
6889082 | Bolling et al. | May 2005 | B2 |
7011620 | Siess | Mar 2006 | B1 |
7021905 | Torrey et al. | Apr 2006 | B2 |
7070398 | Olsen et al. | Jul 2006 | B2 |
7229258 | Wood et al. | Jun 2007 | B2 |
7699586 | LaRose et al. | Apr 2010 | B2 |
7972122 | LaRose et al. | Jul 2011 | B2 |
8007254 | LaRose et al. | Aug 2011 | B2 |
8419609 | Shambaugh, Jr. et al. | Apr 2013 | B2 |
8668473 | LaRose et al. | Mar 2014 | B2 |
8790236 | LaRose et al. | Jul 2014 | B2 |
20010031210 | Antaki et al. | Oct 2001 | A1 |
20030091450 | Davis et al. | May 2003 | A1 |
20040241019 | Goldowsky | Dec 2004 | A1 |
20040265153 | Torrey et al. | Dec 2004 | A1 |
20050107657 | Carrier et al. | May 2005 | A1 |
20050135942 | Wood et al. | Jun 2005 | A1 |
20060036127 | Delgado | Feb 2006 | A1 |
20060245959 | LaRose et al. | Nov 2006 | A1 |
20070078293 | Shambaugh et al. | Apr 2007 | A1 |
20070100196 | LaRose et al. | May 2007 | A1 |
20100069847 | LaRose et al. | Mar 2010 | A1 |
20110301403 | LaRose et al. | Dec 2011 | A1 |
20150031936 | LaRose et al. | Jan 2015 | A1 |
20150038769 | LaRose et al. | Feb 2015 | A1 |
Number | Date | Country |
---|---|---|
1278188 | Dec 2000 | CN |
1067054 | Apr 1967 | GB |
2004278375 | Oct 2004 | JP |
2005030296 | Apr 2005 | WO |
2005032620 | Apr 2005 | WO |
2006060260 | Jun 2006 | WO |
2006118600 | Nov 2006 | WO |
Entry |
---|
Advisory Action dated Apr. 27, 2009 in connection with U.S. Appl. No. 11/003,810, filed Dec. 3, 2004. |
Advisory Action dated Feb. 12, 2010 in connection with U.S. Appl. No. 11/118,551, filed Apr. 29, 2005. |
Advisory Action dated Feb. 28, 2011 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005. |
Advisory Action dated Feb. 29, 2012 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005. |
Advisory Action dated Jan. 26, 2010 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 3 pgs. |
Advisory Action dated Oct. 14, 2008 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 4 pgs. |
Australian Examination Report for Application No. 2013257469 dated May 21, 2015. |
Chinese Office Action for Application No. 201210073420.3 dated Jun. 5, 2014. |
Chinese Office Action for Application No. 201210244769.9 dated Jul. 28, 2014. |
Communication dated Nov. 7, 2013 by the European Patent Office in connection with European Patent Application No. 06772018.5. |
European Examination Report for Application No. 06772018.5 dated Oct. 15, 2015. |
Final Office Action dated Aug. 16, 2010 in connection with U.S. Appl. No. 11/445,963, filed Jun. 2, 2006, 13 pgs. |
Final Office Action dated Dec. 10, 2008 in connection with U.S. Appl. No. 11/003,810, filed Dec. 3, 2004. |
Final Office Action dated Jun. 20, 2008 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 9 pgs. |
Final Office Action dated Nov. 18, 2009 in connection with U.S. Appl. No. 11/118,551, filed Apr. 29, 2005. |
Final Office Action dated Oct. 23, 2008 in connection with U.S. Appl. No. 11/118,551, filed Apr. 29, 2005, 15 pgs. |
Final Office Action dated Sep. 28, 2011 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005. |
Final Office Action dated Sep. 13, 2010 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 10 pgs. |
Final Office Action dated Sep. 30, 2009 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 10 pgs. |
Humphrey, Bruce “Coatings—Using Parylene for Medical Substrate Coating”, www.devicelink.com/ (Jan. 1996) 5 pages. |
International Preliminary Report on Patentability for PCT/US05/42495, dated Apr. 17, 2008, 9 pgs. |
International Preliminary Report on Patentability issued by the International Bureau of WIPO dated Apr. 8, 2008 in connection with International Application No. PCT/US2006/21544, dated Dec. 16, 2006, 6 pgs. |
International Search Report dated Apr. 17, 2008 by the International Searching Authority (ISA/US) in connection with International Application No. PCT/US2005/42495. |
International Search Report issued by the International Searching Authority (ISA/US) in connection with International Application No. PCT/US2005/35964, dated Aug. 20, 2007, 2 pgs. |
International Search Report issued by the International Searching Authority (ISA/US) in connection with International Application No. PCT/US2006/21544, dated Dec. 13, 2006, 2 pgs. |
MMPA Standard No. 0100-00; Standard Specifications for Permanent Magnet Materials; (Magnetic Material Producers Association; (28 pgs), Jun. 6, 2006. |
Notice of Allowability dated Oct. 21, 2013 in connection with U.S. Appl. No. 13/212,014, filed Aug. 17, 2011. |
Notice of Allowance dated Aug. 28, 2009 in connection with U.S. Appl. No. 11/003,810, filed Dec. 3, 2004. |
Notice of Allowance dated Dec. 9, 2010 in connection with U.S. Appl. No. 11/118,551, filed Apr. 29, 2005. |
Notice of Allowance dated Feb. 17, 2011 in connection with U.S. Appl. No. 11/445,963, filed Jun. 2, 2006, 9 pgs. |
Notice of Allowance dated Jan. 24, 2013 in connection with U.S. Appl. No. 11/992,997, filed Apr. 1, 2008. |
Notice of Allowance dated Jan. 31, 2013 in connection with U.S. Appl. No. 11/243,772, filed Oct. 5, 2005. |
Notice of Allowance dated Jan. 12, 2010 in connection with U.S. Appl. No. 11/003,810, filed Dec. 3, 2004. |
Office Action dated Apr. 17, 2009 in connection with U.S. Appl. No. 11/118,551, filed Apr. 29, 2005, 17 pgs. |
Office Action dated Dec. 27, 2011 in connection with U.S. Appl. No. 11/992,997, filed Apr. 1, 2008. |
Office Action dated Dec. 19, 2008 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 9 pgs. |
Office Action dated Jan. 19, 2010 in connection with U.S. Appl. No. 11/445,963, filed Jun. 2, 2006, 10 pgs. |
Office Action dated Jul. 12, 2010 in connection with U.S. Appl. No. 11/118,551, filed Apr. 29, 2005. |
Office Action dated Mar. 29, 2011 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005. |
Office Action dated Mar. 11, 2013 in connection with U.S. Appl. No. 13/212,014, filed Aug. 17, 2011. |
Office Action dated Mar. 17, 2008 in connection with U.S. Appl. No. 11/003,810, filed Dec. 3, 2004. |
Office Action dated Mar. 20, 2008 in connection with U.S. Appl. No. 11/118,551, filed Apr. 29, 2005, 11 pgs. |
Office Action dated Mar. 24, 2010 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 10 pgs. |
Office Action dated Oct. 3, 2012 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005. |
Office Action dated Sep. 10, 2007 in connection with U.S. Appl. No. 11/243,722, filed Oct. 5, 2005, 13 pgs. |
Office Action dated Sep. 22, 2009 in connection with U.S. Appl. No. 11/445,963, filed Jun. 2, 2006, 8 pgs. |
Office Action dated Sep. 28, 2012 in connection with U.S. Appl. No. 13/212,014, filed Aug. 17, 2011. |
Olsen, Don B., Presidential Address—The History of Continuous-Flow Blood Pumps. Artificial Organs 24(6), 401-404, Mar. 2000. |
Response to Office Action dated Mar. 11, 2013, filed Jun. 7, 2013, in connection with U.S. Appl. No. 13/212,014, filed Aug. 17, 2011. |
Response to Office Action dated Sep. 28, 2012, filed Nov. 26, 2012, in connection with U.S. Appl. No. 13/212,014, filed Aug. 17, 2011. |
Siegenthaler et al. “Mechanical Circulatory Assistance for Acute and Chronic Heart Failure: a Review of Current Technology & Clinical Practice”, Journal of Interventional Cardiology, vol. 16/No. 6 (2003) pp. 563-572. |
Song et al., (2003) Axial Flow Blood Pumps. ASAIO Journal 2003, 355-364. |
Written Opinion for International Application No. PCT/US05/42495, dated Apr. 17, 2008, 7 pgs. |
Written Opinion of the International Searching Authority issued by the International Searching Authority (ISA/US) in connection with International Application No. PCT/US2005/35964, dated Aug. 20, 2007, 3 pgs. |
Written Opinion of the International Searching Authority dated Dec. 13, 2006 by the International Searching Authority (ISA/US) in connection with International Application No. PCT/US2006/21544. |
Number | Date | Country | |
---|---|---|---|
20180028734 A1 | Feb 2018 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15151058 | May 2016 | US |
Child | 15669520 | US | |
Parent | 14327971 | Jul 2014 | US |
Child | 15151058 | US | |
Parent | 11992997 | US | |
Child | 14327971 | US | |
Parent | 11243722 | Oct 2005 | US |
Child | 11992997 | US |